Compare PLMR & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLMR | AMRX |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.7B |
| IPO Year | 2019 | 2018 |
| Metric | PLMR | AMRX |
|---|---|---|
| Price | $114.86 | $12.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $153.60 | $15.60 |
| AVG Volume (30 Days) | 245.1K | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 60.04 | ★ 157.89 |
| EPS | ★ 1.57 | 0.19 |
| Revenue | ★ $875,967,000.00 | N/A |
| Revenue This Year | $192.25 | $4.48 |
| Revenue Next Year | $19.34 | $7.13 |
| P/E Ratio | $72.46 | ★ $62.03 |
| Revenue Growth | ★ 58.16 | N/A |
| 52 Week Low | $107.51 | $7.02 |
| 52 Week High | $175.85 | $15.42 |
| Indicator | PLMR | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 43.28 |
| Support Level | $109.89 | $11.60 |
| Resistance Level | $136.20 | $12.85 |
| Average True Range (ATR) | 4.75 | 0.41 |
| MACD | 0.18 | -0.12 |
| Stochastic Oscillator | 47.67 | 23.32 |
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. It provides insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The company's Earthquake product generate high premium.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.